Thursday, August 27, 2026 should have been a green day across the board. Nvidia jumped as much as 9.3% after a blowout earnings beat and raised guidance, pulling the Nasdaq up 1.51% and lifting the S&P 500 alongside strong prints from Salesforce and CrowdStrike. But even on a day this bullish for the broader tape, a handful of individual stocks got crushed on company-specific news that had nothing to do with AI chips. Here are the Top Losing Stocks Today and exactly why each one fell.
Today’s Market Snapshot
- S&P 500: +0.51% to +0.68% intraday, lifted by Nvidia’s earnings reaction
- Nasdaq Composite: +1.43% to +1.51%, its best session in weeks
- Nvidia (NVDA): Up as much as 9.3% after beating fiscal Q2 estimates and issuing guidance that topped Wall Street’s expectations
- Backdrop: Kansas City Fed President Jeffrey Schmid called inflation “stubborn” and “sticky” from the Jackson Hole symposium, adding a note of caution even as tech stocks rallied. Markets are also digesting reports that the Trump administration is weighing a new, broader round of semiconductor tariffs.
- The irony of today’s list: Despite roughly 48.5% of individual issues declining versus 48.1% advancing, the index-level gains from a handful of mega-cap winners masked genuine pain in several individual names.
1. Wendy’s Company (WEN) — Down as Much as 14.7% as a Buyout Talk Collapses
| Metric | Value |
|---|---|
| Session Loss | -12.4% to -14.7% (premarket to intraday range) |
| Trian’s Stake | ~16% of Wendy’s shares |
| Prior Catalyst Gain (Aug 12) | +14.7% on initial buyout report |
| Recent High | Roughly nine-month high, ~$1.7 billion market value |
Wendy’s shares reversed hard after Reuters reported that Nelson Peltz’s Trian Fund Management has stepped back from a potential buyout of the burger chain, walking away from talks that had sent the stock surging 14.7% just two weeks earlier on August 12. Trian, a longtime Wendy’s shareholder holding around 16% of the company, had reportedly been preparing a bid with a consortium of investors including Bugatti-backed BlueFive Capital and Wendy’s franchisee Flynn Group. According to Reuters’ sources, Trian grew concerned about Wendy’s recent trading price, valuation multiples, and current strategic direction — though the firm reportedly remains open-minded about its future intentions.
Forecast
With the take-private premium now removed from the stock, Wendy’s will likely need to demonstrate standalone operational improvement to hold onto any of the gains built up since mid-August. Watch for whether Trian discloses any further stake changes in upcoming SEC filings, which would be the clearest signal of the fund’s next move.
2. Hormel Foods Corporation (HRL) — Down 9.1% on a Guidance Cut
| Metric | Value |
|---|---|
| Session Loss | -9.1% |
| Catalyst | Revenue miss + cut full-year sales outlook |
Hormel Foods, the maker of Spam, Skippy, and Applegate, fell sharply after missing Wall Street’s revenue expectations and cutting its full-year sales outlook. The food processing and manufacturing company’s guidance reduction signals continued pressure on consumer packaged-goods pricing power, a theme that has weighed on several food companies throughout 2026 as shoppers trade down to private-label alternatives amid persistent inflation.
Forecast
Hormel’s next scheduled update will be closely watched for whether the guidance cut reflects a temporary, category-specific slowdown or a broader trend across its protein and grocery segments. Investors should watch commentary on input costs and promotional activity for early signs of stabilization.
3. HP Inc. (HPQ) — Fell as Much as 12.5% Premarket, Settling Near -3% by the Close
| Metric | Value |
|---|---|
| Premarket Loss | -7.1% to -12.5% |
| Closing Loss | Roughly -3% |
| PC Shipment Decline | -16% |
| Full-Year FCF Guidance (raised) | ~$3.1 billion |
The Catalyst — and a Genuine Intraday Recovery Story
HP delivered a fiscal Q3 beat but still opened sharply lower as investors focused on a 16% decline in PC shipments and margin contraction, with rising memory-chip costs (tied to the same NAND and DRAM price surge that’s been squeezing PC makers all year) outweighing the headline beat. Notably, most of HP’s sales growth came from price increases implemented specifically to offset those soaring input costs rather than genuine unit demand growth — a distinction that initially spooked investors.
Why the Stock Clawed Back Most of Its Losses
As the session progressed, HP shares recovered from as much as -12.5% premarket to close down only around 3%, as investors digested a more nuanced picture: the company’s AI PC unit posted double-digit sales growth and now accounts for 46% of HP’s total PC business, with management targeting more than 70% by 2028 — a meaningful multi-year replacement-cycle opportunity. Trading at roughly 10 times forward earnings against $3.1 billion in projected free cash flow versus a $33 billion enterprise value, some analysts argued the stock remained cheap even after the mixed quarter.
Forecast
| Level | Type | Note |
|---|---|---|
| — | AI PC mix | Currently 46% of PC business, targeted to exceed 70% by 2028 |
| — | Valuation | ~10x forward earnings, seen as inexpensive if AI PC transition executes |
What to watch: Whether memory-cost inflation continues to squeeze margins into the holiday shopping season, and whether AI PC adoption accelerates enough to offset unit-shipment softness.
4. Moderna, Inc. (MRNA) — Down 5.69% on Dilution Concerns From a $2 Billion Debt Raise
| Metric | Value |
|---|---|
| Price | ~$141.90 |
| Session Loss | -5.69% (some intraday readings as steep as -6%) |
| Day’s Range | $137.72–$148.59 |
| Debt Offering | $2.0 billion in convertible senior notes due 2032 (plus up to $300 million in over-allotment) |
| 52-Week High | $176.66 |
| 52-Week Low | $22.28 |
Moderna announced a private placement of $2.0 billion in convertible senior notes due 2032, immediately driving investor concern over share dilution and expanded long-term liabilities. The timing compounds an already volatile stretch for the stock: Moderna surged 176.97% just last week on positive Phase 3 melanoma vaccine data with Merck, then plunged roughly 20-25% days later as investors took profits — and today’s decline adds a third major swing to that same two-week saga.
Fundamentals
The company continues to face real financial headwinds: a Q2 GAAP net loss of $782 million against high ongoing cost of sales, with core COVID-19 vaccine revenue remaining suppressed. While the recent Phase 3 cancer-therapy data was genuinely positive, analysts caution that broad regulatory approval and material revenue realization for intismeran autogene remain years away, given the operational complexity of scaling bespoke, patient-specific manufacturing. On a brighter note, the FDA also approved Moderna’s updated 2026-2027 Spikevax and mNEXSPIKE formulas today, a smaller but still positive regulatory development that got overshadowed by the debt-offering news.
Forecast
| Level | Type | Note |
|---|---|---|
| $137.72 | Today’s intraday low | Near-term support |
| $141.90 (current) | Trading zone | Reference price |
| $148.59 | Today’s intraday high | Near-term resistance |
| $174.38–$176.66 | Recent high / 52-week high | Distant recovery target after the cancer-vaccine spike |
5. Celsius Holdings, Inc. (CELH) — Down 5.5% on an Analyst Downgrade
| Metric | Value |
|---|---|
| Session Loss | -5.5% |
| New Price Target | $35 (up from $30) |
| Rating Change | Buy → Hold (Deutsche Bank) |
Celsius fell after Deutsche Bank downgraded the energy-drink maker’s shares from Buy to Hold, even while simultaneously raising its price target to $35 from $30. The seemingly contradictory move signals that Deutsche Bank sees the stock’s valuation as having caught up to its fundamentals — the firm’s note effectively argued that the risk-reward has become less compelling near current levels, even though the underlying business outlook improved enough to justify a higher target.
Forecast
Watch for whether other analysts follow Deutsche Bank’s lead with similar valuation-based downgrades, or whether Celsius’s continued market-share gains in the energy-drink category are enough to keep the bulls in control despite today’s pullback.
6. Spotify Technology S.A. (SPOT) — Trading Lower Amid Lingering Margin Concerns
| Metric | Value |
|---|---|
| Recent Reference Price | ~$479–$480 range |
| Sector Context | Communication services, competing for attention against today’s software and chip rally |
Spotify was named among today’s midday decliners as investor attention rotated heavily toward Nvidia, Salesforce, and CrowdStrike, leaving communication-services names like Spotify without a fresh company-specific catalyst to compete for capital. The stock has faced lingering questions in recent weeks about operating-expense growth tied to AI infrastructure and marketing investment, alongside continued insider selling by co-CEO Gustav Söderström under a structured trading plan — factors that have kept a lid on the stock even as Spotify recently expanded its share buyback authorization to $2.2 billion.
Forecast
Spotify’s next major catalyst will likely be its Q3 2026 earnings report. Until then, watch whether the expanded buyback program provides a technical floor for the stock during periods of broader market rotation away from communication-services names.
The Day’s Dominant Theme: Idiosyncratic Pain Beneath a Green Tape
Today’s losers list is a useful reminder that a strong index-level session doesn’t mean every stock participates. Wendy’s fell on collapsed M&A speculation, Hormel and Celsius fell on guidance and rating concerns specific to consumer staples, HP fell (then partially recovered) on a nuanced earnings reaction, and Moderna and Spotify both fell on capital-structure and rotation dynamics rather than any change to their underlying growth stories. With roughly half of individual stocks declining even as the S&P 500 and Nasdaq posted some of their best gains in weeks, today is a textbook example of “average stock” performance diverging sharply from “average index” performance.
Sector Sentiment Snapshot
- Consumer staples and restaurants: Clear laggards today, with Wendy’s, Hormel, and Celsius all posting notable declines on company-specific news.
- Technology hardware: Mixed — HP’s initial plunge and partial recovery shows investors are willing to look past near-term margin pressure if a credible longer-term growth story (AI PCs) is attached.
- Biotech and communication services: Both Moderna and Spotify traded lower on capital-allocation and attention-rotation dynamics rather than deteriorating fundamentals.
Follow TNN for daily stock market news and financial news today.
Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss. Support and resistance levels cited are technical analysis estimates based on historical price data and do not guarantee future price behaviour. Always complete independent due diligence prior to executing equity trades.